LENSAR, Inc. (LNSR) Misses Q3 EPS by 6c; Reports Cash and Cash Equivalents of $32.3M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
LENSAR Reports Third Quarter 2021 Financial Results and Provides Business Update
November 8, 2021 7:00 AM ESTThird Quarter 2021 Procedure Volumes Increase 23% over 2020 Levels
Cash and Cash Equivalents of $32.3 Million reflect Cash Utilization of $2.2 Million in the Quarter
ORLANDO, Fla.--(BUSINESS WIRE)-- LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the quarter ended September 30, 2021 and provided an update on key strategic and operational initiatives.
The third quarter was one of continued progress on both the commercial and research and... More
